✦ LIBER ✦

Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas–kidney transplantation under antibody preconditioning

✍ Scribed by K. Keven; A. Basu; H.P. Tan; N. Thai; A. Khan; A. Marcos; T.E. Starzl; R. Shapiro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytomegalovirus prophylaxis with valganc

✍ Gaetano Ciancio; George W Burke; Adela Mattiazzi; Zvi Leibovici; Lorraine Dowdy; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Superior Efficacy of Oral Ganciclovir Ov

✍ T Somerville; G Hurst; R Alloway; A Gaber; M.H Shokouh-Amiri; R Stratta 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Ganciclovir prophylaxis for cytomegalovi

✍ A Lo; R.J Stratta; M.F Egidi; A.T Kizilisik; M.H Shokouh-Amiri; H.P Grewal; J Tr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Ganciclovir exposure under a 450 mg dail

✍ Oriol Manuel; Manuel Pascual; Nancy Perrottet; Frédéric Lamoth; Jean-P. Venetz; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Incidence, Risk Factors, and Outcome of

✍ Pau Montesinos; Jaime Sanz; Susana Cantero; Ignacio Lorenzo; Guillermo Martín; S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Safety of using hepatitis B virus core a

✍ Enver Akalin; Scott Ames; Vinita Sehgal; Barbara Murphy; Jonathan S Bromberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB